The estimated Net Worth of Beau Standish is at least $1.42 Million dollars as of 15 July 2021. Dr Standish owns over 26,208 units of SeaSpine Corp stock worth over $96,354 and over the last 3 years he sold SPNE stock worth over $977,728. In addition, he makes $345,149 as Pres of Enabling Technologies at SeaSpine Corp.
Sign up
Dr D SPNE stock SEC Form 4 insiders trading
Dr has made over 3 trades of the SeaSpine Corp stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 50,000 units of SPNE stock worth $286,500 on 14 July 2022.
The largest trade he's ever made was selling 50,000 units of SeaSpine Corp stock on 14 July 2022 worth over $286,500. On average, Dr trades about 10,789 units every 46 days since 2021. As of 15 July 2021 he still owns at least 10,100 units of SeaSpine Corp stock.
You can see the complete history of Dr Standish stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Beau Standish P.Eng., Ph.D. biography
Dr. Beau Standish P.Eng., Ph.D. is the Pres of Enabling Technologies at SeaSpine Corp.
What is the salary of Dr D?
As the Pres of Enabling Technologies of SeaSpine Corp, the total compensation of Dr D at SeaSpine Corp is $345,149. There are 8 executives at SeaSpine Corp getting paid more, with Keith Valentine having the highest compensation of $1,840,570.
How old is Dr D?
Dr D is 41, he's been the Pres of Enabling Technologies of SeaSpine Corp since . There are 20 older and 1 younger executives at SeaSpine Corp. The oldest executive at SeaSpine Holdings Corp is Keith Bradley, 75, who is the Independent Director.
What's Dr D's mailing address?
Beau's mailing address filed with the SEC is SeaSpine, 5770, Armada Drive, Carlsbad, San Diego County, California, 92009-1114, United States.
Insiders trading at SeaSpine Corp
Over the last 9 years, insiders at SeaSpine Corp have traded over $2,659,931 worth of SeaSpine Corp stock and bought 297,805 units worth $3,591,897 . The most active insiders traders include Stuart Essig, Richard E Caruso, and Keith Valentine. On average, SeaSpine Corp executives and independent directors trade stock every 39 days with the average trade being worth of $151,762. The most recent stock trade was executed by John J. Winge on 1 January 2023, trading 4,868 units of SPNE stock currently worth $46,441.
What does SeaSpine Corp do?
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.
What does SeaSpine Corp's logo look like?
Complete history of Dr Standish stock trades at SeaSpine Corp
SeaSpine Corp executives and stock owners
SeaSpine Corp executives and other stock owners filed with the SEC include:
-
Keith Valentine,
President, Chief Executive Officer, Director -
Keith C. Valentine,
Pres, CEO & Director -
John Bostjancic,
Chief Financial Officer, Senior Vice President, Treasurer -
Tyler Lipschultz,
Senior Vice President, Orthobiologics and Business Development -
Patrick Keran,
Vice President, General Counsel, Secretary -
John Winge,
Vice President of Sales -
John J. Bostjancic,
Sr. VP, CFO & Treasurer -
Patrick L. Keran,
Sr. VP, Gen. Counsel & Sec. -
Dr. Beau Standish P.Eng., Ph.D.,
Pres of Enabling Technologies -
Kimberly Commins-Tzoumakas,
Independent Director -
Renee Gaeta,
Independent Director -
Kirtley Stephenson,
Independent Non-Executive Chairman of the Board -
Stuart Essig,
Lead Independent Director -
Michael Fekete,
Independent Director -
Keith Bradley,
Independent Director -
John Henneman,
Independent Director -
Dennis Cirino,
Senior Vice President, Global Spinal Systems -
Hollis Winkler,
Sr. VP of HR -
Patrick L. Keran J.D.,
Sr. VP, Gen. Counsel & Sec. -
Dr. Frank Vizesi,
Chief Scientific Officer -
Shaeffer Bannigan,
Sr. Director of Product Devel. -
Paul Benny,
VP, Corp. Controller, Assistant Treasurer & Assistant Sec. -
Dr. Beau Standish Ph.D.,
Pres of Enabling Technologies -
Dennis L. Cirino,
Sr. VP of Global Spinal Systems -
Tyler P. Lipschultz,
Sr. VP of Orthobiologics & Bus. Devel. -
John J. Winge,
VP of Sales -
Carrie Mendivil,
Head of Investor Relations -
James M Sullivan,
Director -
Cheryl R Blanchard,
Director -
Brian D. Baker,
VP, Global Operations -
Richard E Caruso,
10% owner -
Shweta Maniar,
Director -
Life Sciences Corp Integra ...,
-
Beau Standish,
President, Enabling Tech -
Angela Steinway,
Director